Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
26.01
-1.13 (-4.16%)
At close: Oct 17, 2025, 4:00 PM EDT
26.18
+0.17 (0.65%)
After-hours: Oct 17, 2025, 7:58 PM EDT
Moderna Stock Forecast
Stock Price Forecast
The 13 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $40.46, which forecasts a 55.56% increase in the stock price over the next year. The lowest target is $15 and the highest is $70.
Price Target: $40.46 (+55.56%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 13 | 13 | 13 | 12 | 12 | 8 |
Sell | 3 | 3 | 3 | 4 | 4 | 4 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 19 | 19 | 19 | 19 | 19 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold Maintains $31 → $32 | Hold | Maintains | $31 → $32 | +23.03% | Oct 10, 2025 |
Leerink Partners | Leerink Partners | Sell Maintains $18 → $15 | Sell | Maintains | $18 → $15 | -42.33% | Aug 22, 2025 |
Barclays | Barclays | Hold Maintains $40 → $31 | Hold | Maintains | $40 → $31 | +19.18% | Aug 4, 2025 |
JP Morgan | JP Morgan | Sell Maintains $33 → $26 | Sell | Maintains | $33 → $26 | -0.04% | May 22, 2025 |
UBS | UBS | Strong Buy Maintains $78 → $70 | Strong Buy | Maintains | $78 → $70 | +169.13% | May 2, 2025 |
Financial Forecast
Revenue This Year
1.96B
from 3.24B
Decreased by -39.37%
Revenue Next Year
2.17B
from 1.96B
Increased by 10.45%
EPS This Year
-9.98
from -9.28
EPS Next Year
-8.07
from -9.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.4B | 3.2B | |||
Avg | 2.0B | 2.2B | |||
Low | 1.5B | 1.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -26.1% | 61.4% | |||
Avg | -39.4% | 10.4% | |||
Low | -53.3% | -33.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -9.18 | -6.00 | |||
Avg | -9.98 | -8.07 | |||
Low | -10.50 | -9.93 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.